Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Inflammasomes: Clinical and Therapeutic Implications
Details
Extensive coverage of the roles played by inflammasomes in various diseases
Examines the inflammasome as a potential therapeutic target
Discusses pharmacological developments in inflammasome inhibition
Extensive coverage of the roles played by inflammasomes in various diseases Examines the inflammasome as a potential therapeutic target Discusses pharmacological developments in inflammasome inhibition
Autorentext
Mario D Cordero is Research Associate at the University of Sevilla. He studies the role of inflammasomes in metabolic and cardiovascular diseases, with special attention on the implication of NLRP3 in age-associated diseases. He is also involved in the evaluation of inflammasome inhibitors in rare diseases.Dr Cordero is one of the editors of volume no. 107 on AMP-activated protein kinases in the same series.
Elísabet Alcocer-Gómez is Research Associate at the University of Sevilla. Her scientific interest is the implication of inflammasome complexes in psychiatric diseases and the effect of psychiatric drugs on the inhibition or induction of inflammasome activation.
Klappentext
This volume focuses on the role of inflammasomes in a variety of diseases and their therapeutic options. It gives an overview of the current studies elucidating the molecular implications in the medical and clinical contexts. It covers inflammasomes as potential therapeutic targets and evaluates the benefits of inflammasome inhibitors.
Inhalt
Chapter 1: Bases of the inflammasomes in the clinical practice. A brief introduction.- Chapter 2: The Inflammasomes in Cardiovascular Disease.- Chapter 3: Inflammasomes in CNS diseases.- Chapter 4: Lung Diseases.- Chapter 5: Traumatic Injury.- Chapter 6: Inflammasome in the pathogenesis of pulmonary diseases.- Chapter 7: Inflammasome and Oral Diseases.- Chapter 8: Inflammasomes in the kidney.- Chapter 9: Pro-inflammatory actions of red blood cell-derived DAMPs.- Chapter 10: Role of Inflammasomes in the Development of Gastrointestinal Diseases.- Chapter 11: Inflammasomes in bone diseases.- Chapter 12: Inflammasome in Cancer.- Chapter 13: Aging and the inflammasomes.- Chapter 14: Genetics of inflammasome.- Chapter 15: Therapeutic implications of the inflammasomes. <p
Weitere Informationen
- Allgemeine Informationen
- GTIN 09783319893891
- Editor Elísabet Alcocer-Gómez, Mario D. Cordero
- Sprache Englisch
- Auflage 1st edition 2018
- Größe H241mm x B160mm x T28mm
- Jahr 2018
- EAN 9783319893891
- Format Fester Einband
- ISBN 3319893890
- Veröffentlichung 17.09.2018
- Titel Inflammasomes: Clinical and Therapeutic Implications
- Untertitel Experientia Supplementum 108
- Gewicht 776g
- Herausgeber Springer International Publishing
- Anzahl Seiten 408
- Lesemotiv Verstehen
- Genre Medical Books